advertisement

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Clinical Trials

Page
12345›»

Cempra Announces The Completion Of Phase 1 Studies For CEM-101, A Next-Generation Macrolide

Cempra Pharmaceuticals today announced the successful completion of Phase 1...

Wednesday, March 10, 2010 Source: Cempra Pharmaceuticals

Diamyd Medical: Diamyd US Phase III Study Well Under Way

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Diamyd Medical (STO:DIAMB)(Pink...

Wednesday, March 10, 2010 Source: BUSINESS WIRE

Start Of Phase I/II Gene Therapy Clinical Trial For Hemophilia B

Amsterdam Molecular Therapeutics , a leader in the field of human gene therapy,...

Tuesday, March 09, 2010 Source: Amsterdam Molecular Therapeutics B.V

Scivanta Medical Corporation Announces Results For Initial Clinical Trial For The Scivanta Cardiac Monitoring System

Scivanta Medical Corporation , today announced that the results of its initial...

Tuesday, March 09, 2010 Source: Scivanta Medical Corporation

Chimerix Initiates Phase 2 Study Of CMX001 In Stem Cell Transplant Recipients Seropositive For Cytomegalovirus

Chimerix, Inc., a biotechnology company developing orally-available antiviral...

Tuesday, March 09, 2010 Source: Chimerix, Inc.

Cellectar Completes Enrollment In Phase I Clinical Trial Of Lead Drug Candidate (131)I-CLR1404 For The Treatment Of Solid Malignancies

MADISON, Wis., March 9 /PRNewswire/ --Cellectar, Inc., a privately held radiopharmaceutical...

Tuesday, March 09, 2010 Source: Cellectar, Inc.

Lithera Reports Positive Phase IIa Clinical Study Results For LIPO-102, A Novel Treatment For Localized Fat Reduction

Lithera, Inc. today announced positive results from a Phase IIa clinical study...

Tuesday, March 09, 2010 Source: GLOBE NEWSWIRE

INSYS Therapeutics Announces Positive Phase III Efficacy Trial Results For Fentanyl Sublingual Spray

INSYS Therapeutics, Inc. announces positive results from the pivotal phase III...

Tuesday, March 09, 2010 Source: PRNewswire

INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results For Fentanyl Sublingual Spray

INSYS Therapeutics, Inc. announces positive results from the pivotal phase III...

Monday, March 08, 2010 Source: INSYS Therapeutics, Inc.

Nektar Announces Positive Phase 2 Clinical Data From First Stage Of NKTR-102 Study In Women With Platinum-Resistant Ovarian Cancer

Nektar Therapeutics today announced preliminary progression-free survival data...

Monday, March 08, 2010 Source: Nektar Therapeutics
Page
12345›»

News Search

Search News By Keywords

News Sections

New Technologies

Eppendorf Varispenser(r) Bottletop dispensers
Eppendorf Varispenser® Bottletop...
from Eppendorf North America
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)






 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading